Literature DB >> 15044690

Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.

L H Castilla1, P Perrat, N J Martinez, S F Landrette, R Keys, S Oikemus, J Flanegan, S Heilman, L Garrett, A Dutra, S Anderson, G A Pihan, L Wolff, P P Liu.   

Abstract

Acute myeloid leukemia subtype M4 with eosinophilia is associated with a chromosome 16 inversion that creates a fusion gene CBFB-MYH11. We have previously shown that CBFB-MYH11 is necessary but not sufficient for leukemogenesis. Here, we report the identification of genes that specifically cooperate with CBFB-MYH11 in leukemogenesis. Neonatal injection of Cbfb-MYH11 knock-in chimeric mice with retrovirus 4070A led to the development of acute myeloid leukemia in 2-5 months. Each leukemia sample contained one or a few viral insertions, suggesting that alteration of one gene could be sufficient to synergize with Cbfb-MYH11. The chromosomal position of 67 independent retroviral insertion sites (RISs) was determined, and 90% of the RISs mapped within 10 kb of a flanking gene. In total, 54 candidate genes were identified; six of them were common insertion sites (CISs). CIS genes included members of a zinc finger transcription factors family, Plag1 and Plagl2, with eight and two independent insertions, respectively. CIS genes also included Runx2, Myb, H2T24, and D6Mm5e. Comparison of the remaining 48 genes with single insertion sites with known leukemia-associated RISs indicated that 18 coincide with known RISs. To our knowledge, this retroviral genetic screen is the first to identify genes that cooperate with a fusion gene important for human myeloid leukemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044690      PMCID: PMC387350          DOI: 10.1073/pnas.0400930101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.

Authors:  F Vaillant; K Blyth; A Terry; M Bell; E R Cameron; J Neil; M Stewart
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

2.  PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II.

Authors:  M L Voz; N S Agten; W J Van de Ven; K Kas
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

3.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

4.  Leukaemia disease genes: large-scale cloning and pathway predictions.

Authors:  J Li; H Shen; K L Himmel; A J Dupuy; D A Largaespada; T Nakamura; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

5.  Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta.

Authors:  K Sasaki; H Yagi; R T Bronson; K Tominaga; T Matsunashi; K Deguchi; Y Tani; T Kishimoto; T Komori
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

6.  Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.

Authors:  K Blyth; A Terry; N Mackay; F Vaillant; M Bell; E R Cameron; J C Neil; M Stewart
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

7.  AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.

Authors:  Y Yuan; L Zhou; T Miyamoto; H Iwasaki; N Harakawa; C J Hetherington; S A Burel; E Lagasse; I L Weissman; K Akashi; D E Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

8.  PLAG1 fusion oncogenes in lipoblastoma.

Authors:  M K Hibbard; H P Kozakewich; P Dal Cin; R Sciot; X Tan; S Xiao; J A Fletcher
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

9.  A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice.

Authors:  B J Feldman; T Hampton; M L Cleary
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

10.  SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL.

Authors:  M Sattler; S Verma; Y B Pride; R Salgia; L R Rohrschneider; J D Griffin
Journal:  J Biol Chem       Date:  2000-10-12       Impact factor: 5.157

View more
  42 in total

1.  An Integrated Genetic-Genomic Approach for the Identification of Novel Cancer Loci in Mice Sensitized to c-Myc-Induced Apoptosis.

Authors:  Susan M Mendrysa; Keiko Akagi; Jean Roayaei; Wen-Hui Lien; Neal G Copeland; Nancy A Jenkins; Robert N Eisenman
Journal:  Genes Cancer       Date:  2010-05

2.  KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.

Authors:  Ling Zhao; Jan J Melenhorst; Lemlem Alemu; Martha Kirby; Stacie Anderson; Maggie Kench; Shelley Hoogstraten-Miller; Lauren Brinster; Yasuhiko Kamikubo; D Gary Gilliland; P Paul Liu
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

3.  Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia.

Authors:  Daphne de Jong; Siegfried Janz
Journal:  J Pathol       Date:  2010-07       Impact factor: 7.996

4.  Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines.

Authors:  Albana Gattelli; María N Zimberlin; Roberto P Meiss; Lucio H Castilla; Edith C Kordon
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

5.  The human pseudoxanthoma elasticum gene ABCC6 is transcriptionally regulated by PLAG family transcription factors.

Authors:  Marcin Ratajewski; Wim J M Van de Ven; Grzegorz Bartosz; Lukasz Pulaski
Journal:  Hum Genet       Date:  2008-10-12       Impact factor: 4.132

6.  Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.

Authors:  Yasuhiko Kamikubo; Ling Zhao; Mark Wunderlich; Takeshi Corpora; R Katherine Hyde; Thomas A Paul; Mondira Kundu; Lisa Garrett; Sheila Compton; Gang Huang; Linda Wolff; Yoshiaki Ito; John Bushweller; James C Mulloy; P Paul Liu
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

7.  Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.

Authors:  Ya-Huei Kuo; Sayyed K Zaidi; Svetlana Gornostaeva; Toshihisa Komori; Gary S Stein; Lucio H Castilla
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

8.  Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.

Authors:  Michaela Rodenburg; Meike Fischer; Afra Engelmann; Stephanie O Harbers; Marion Ziegler; Jürgen Löhler; Carol Stocking
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.

Authors:  Christopher Slape; Leah Y Liu; Sarah Beachy; Peter D Aplan
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

10.  PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.

Authors:  Gang Zheng; Jinying Ning; Yu-Chung Yang
Journal:  Biochem Biophys Res Commun       Date:  2007-10-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.